ICD Tachycardia Discrimination Using Dual-Vector Morphology Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable cardioverter defibrillators (ICDs) face challenges in accurately discriminating between tachycardia events to deliver therapy with high specificity, while conserving battery charge and minimizing patient exposure to unnecessary shocks.
Innovation Solution
The system employs a combination of interval-based and morphology analysis of cardiac signals, supplemented with sensors for tissue oxygenation, respiration, and patient activity to enhance tachycardia discrimination, and delivers therapy only when necessary, using a subcutaneous ICD with optimized electrode placement and vector selection for improved accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ICD delivers therapy for every detected tachycardia event to ensure high sensitivity, then patient safety is improved, but battery charge is depleted faster and patient exposure to unnecessary shocks increases
Solution Approach 1:
The patent changes the parameters used for tachycardia detection from rate-based alone to a combination of rate-based and morphology-based parameters. By analyzing waveform characteristics alongside heart rate, the system achieves better discrimination between true VT events and non-VT tachycardias, enabling more selective therapy delivery that conserves battery while maintaining safety
Solution Approach 2:
The patent introduces morphology analysis as an intermediary step between rate detection and therapy delivery. This intermediate discrimination layer filters out false positive tachycardia detections, allowing the system to withhold unnecessary therapies and conserve battery charge while still responding appropriately to true malignant arrhythmias
2Reliability
If ICD delivers higher voltage therapy to ensure termination of detected tachycardia, then therapy effectiveness is improved, but patient exposure to painful shocks increases and battery charge is depleted faster
Solution Approach 1:
The patent changes the detection parameters to include morphology analysis, enabling more precise identification of true VT events. This precision allows the system to deliver therapy only when genuinely needed, avoiding unnecessary high-voltage shocks and reducing patient exposure to painful therapies while maintaining effectiveness for true malignant arrhythmias
3Device complexity
If ICD uses rate-based detection alone for tachycardia identification, then device complexity is minimized, but discrimination specificity between VT and non-VT tachycardia is insufficient
Solution Approach 1:
The patent merges rate-based detection with morphology-based analysis into a unified detection system. By combining these two approaches, the system achieves high discrimination specificity for VT detection while managing complexity through integrated algorithm design that leverages the strengths of both methods
Data Source
AI summary
A method and medical device for detecting a cardiac event that includes sensing cardiac signals from a plurality of electrodes, the plurality of electrodes forming a first sensing vector and a second sensing vector, identifying the cardiac event as one of a shockable event and a non-shockable event in response to first processing of a first interval sensed along the first sensing vector during a predetermined sensing window and a second interval simultaneously sensed along the second sensing vector, performing second processing of the first interval and the second interval, different from the first processing, in response to the cardiac event being identified as a shockable event, and determining whether to delay identifying the cardiac event being shockable in response to the second processing of the first interval and the second interval.